Lantheus Holdings Inc
NASDAQ:LNTH
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
51.07
123.62
|
Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Operating Margin
Lantheus Holdings Inc
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Operating Margin Across Competitors
Country | US |
Market Cap | 6.3B USD |
Operating Margin |
32%
|
Country | JP |
Market Cap | 6.8T JPY |
Operating Margin |
28%
|
Country | CH |
Market Cap | 37.9B CHF |
Operating Margin |
13%
|
Country | DK |
Market Cap | 200.9B DKK |
Operating Margin |
27%
|
Country | US |
Market Cap | 16.9B USD |
Operating Margin |
17%
|
Country | KR |
Market Cap | 9.9T KRW |
Operating Margin |
-245%
|
Country | CA |
Market Cap | 6.9B USD |
Operating Margin |
4%
|
Country | CN |
Market Cap | 48.6B CNY |
Operating Margin |
46%
|
Country | US |
Market Cap | 6.1B USD |
Operating Margin |
12%
|
Country | UK |
Market Cap | 4.8B GBP |
Operating Margin |
13%
|
Country | CH |
Market Cap | 4.9B CHF |
Operating Margin |
14%
|
Lantheus Holdings Inc
Glance View
Lantheus Holdings Inc. is a dynamic healthcare company specializing in the development, manufacture, and commercialization of innovative diagnostic imaging agents, particularly in the field of nuclear medicine. Founded in 1956, the company has established a solid reputation for improving patient care through advanced diagnostics, helping healthcare providers make more informed decisions. Lantheus is perhaps best known for its flagship products, including nuclear imaging agents like Pylarify, used in the detection of prostate cancer. With a robust pipeline of novel radiopharmaceuticals in various stages of development, the company is strategically positioned to address unmet needs in diagnostics and therapeutics, thereby enhancing both patient outcomes and shareholder value. For investors, Lantheus represents a compelling opportunity, particularly as the demand for precision medicine continues to grow. With healthcare trends increasingly leaning towards personalized treatment, Lantheus is poised to grow through strategic partnerships, expanding market access, and leveraging new technologies. The company's commitment to innovation is underscored by its recent achievements and promising clinical trials, which have the potential to reshape the landscape of cancer diagnostics and treatment. As Lantheus Holdings continues to expand its portfolio and strengthen its market presence, investors can look forward to both solid financial performance and meaningful contributions to the evolving field of medical diagnostics.
See Also
Operating Margin represents how efficiently a company is able to generate profit through its core operations.
Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.
Based on Lantheus Holdings Inc's most recent financial statements, the company has Operating Margin of 31.7%.